Hansa Biopharma AB (publ) - Special Call
Source: SeekingAlpha
2025-09-25 11:07:48 ET
Hansa Biopharma AB (publ) - Special Call
Company Participants
Renee Aguiar-Lucander - Chief Executive Officer
Richard Philipson - Chief Medical Officer
Monika Tornsen - COO & President of U.S.
Angela Maldonado
...
Read the full article on Seeking Alpha
For further details see:
Hansa Biopharma AB (publ) - Special Call
Hansa Biopharma AB
NASDAQ: HNSBF
HNSBF Trading
-85.0% G/L:
$2.91 Last:
28,750 Volume:
$2.91 Open:
HNSBF Latest News
September 24, 2025 02:06:00 pm
Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation
